TR201719893A2 - Raloksifen Ve En Az Bir Antipsikotik Ajan İçeren Farmasötik Kombinasyon - Google Patents

Raloksifen Ve En Az Bir Antipsikotik Ajan İçeren Farmasötik Kombinasyon Download PDF

Info

Publication number
TR201719893A2
TR201719893A2 TR2017/19893A TR201719893A TR201719893A2 TR 201719893 A2 TR201719893 A2 TR 201719893A2 TR 2017/19893 A TR2017/19893 A TR 2017/19893A TR 201719893 A TR201719893 A TR 201719893A TR 201719893 A2 TR201719893 A2 TR 201719893A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical combination
antipsychotic agent
raloxifene
combination containing
containing raloxifene
Prior art date
Application number
TR2017/19893A
Other languages
English (en)
Inventor
Türkyilmaz Ali̇
Yelken Gülay
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/19893A priority Critical patent/TR201719893A2/tr
Priority to PCT/TR2018/050776 priority patent/WO2019203747A2/en
Publication of TR201719893A2 publication Critical patent/TR201719893A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş, raloksifen veya raloksifenin farmasötik olarak kabul edilebilir bir tuzunu ve en az bir antipsikotik ajan veya söz konusu ajanın farmasötik olarak kabul edilebilir tuzunu içeren bir farmasötik kombinasyon ile ilgili olup; burada kombinasyon, hızlı salım veya modifiye salım veya her iki salımı birlikte sağlayan en az bir salım fazı içermektedir.
TR2017/19893A 2017-12-08 2017-12-08 Raloksifen Ve En Az Bir Antipsikotik Ajan İçeren Farmasötik Kombinasyon TR201719893A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/19893A TR201719893A2 (tr) 2017-12-08 2017-12-08 Raloksifen Ve En Az Bir Antipsikotik Ajan İçeren Farmasötik Kombinasyon
PCT/TR2018/050776 WO2019203747A2 (en) 2017-12-08 2018-12-07 The pharmaceutical combination comprising raloxifene and at least one antipsychotic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/19893A TR201719893A2 (tr) 2017-12-08 2017-12-08 Raloksifen Ve En Az Bir Antipsikotik Ajan İçeren Farmasötik Kombinasyon

Publications (1)

Publication Number Publication Date
TR201719893A2 true TR201719893A2 (tr) 2019-06-21

Family

ID=67952642

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/19893A TR201719893A2 (tr) 2017-12-08 2017-12-08 Raloksifen Ve En Az Bir Antipsikotik Ajan İçeren Farmasötik Kombinasyon

Country Status (2)

Country Link
TR (1) TR201719893A2 (tr)
WO (1) WO2019203747A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026095901A1 (en) * 2024-11-01 2026-05-07 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tablet composition comprising brexpiprazole or a salt thereof

Also Published As

Publication number Publication date
WO2019203747A2 (en) 2019-10-24
WO2019203747A3 (en) 2020-01-09

Similar Documents

Publication Publication Date Title
JOP20200011B1 (ar) مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط nlrp
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
CY1122986T1 (el) Παραγωγα 1,2,4-οξαδιαζολιου ως ανοσοτροποποιητες
CO2020007244A2 (es) Inhibidores de kras g12c
MX2018013983A (es) Inhibidores g12c de kras.
CY1120747T1 (el) Κυκλικες πεπτιδομιμητικες ενωσεις ως ανοσοτροποποιητες
MX391812B (es) Agonista fxr derivado de esteroides.
CY1122182T1 (el) Ανοσοκατασταλτικες φαρμακοτεχνικες μορφες
EA201690848A1 (ru) Производные бициклического пиридила с конденсированными кольцами в качестве ингибиторов fgfr4
PH12018500047B1 (en) Notch pathway signaling inhibitor compounds
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
EA201591397A1 (ru) Хиноксалиноны и дигидрохиноксалиноны как антивирусные средства против респираторно-синцитиального вируса
EA029499B9 (ru) Ингибиторы rorc2 и способы их применения
CY1122352T1 (el) Φαρμακευτικη συνθεση περιεχοντας μιραβεγρονη
EA201690679A1 (ru) Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан
DOP2019000070A (es) Compuestos de aza–indazol para usar en lesiones de tendones y/o ligamentos
EA201491517A1 (ru) N-этил-n-фенил-1,2-дигидро-4,5-дигидрокси-1-метил-2-оксо-3-хинолинкарбоксамид, его получение и применения
MX376741B (es) Composición farmaceútica de sulfonamida
TR201721824A2 (tr) Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon
EA201890896A1 (ru) Твердый препарат для перорального применения, содержащий аморфный солифенацин, и способ его получения
TR201719911A2 (tr) Raloksi̇fen ve en az bi̇r anti̇psi̇koti̇k ajan i̇çeren kompozi̇syon
BR112015032161A2 (pt) método para prevenir e/ou tratar encefalopatia traumática crônica, composição farmacêutica e uso de antagonista do receptor da substância p
MX2020003554A (es) Moduladores de la expresion de enac.
MX384394B (es) Compuesto para uso en la prevención y tratamiento de enfermedades neurodegenerativas.
JOP20200005A1 (ar) تركيبات صيدلية